Bellerophon Announces Poster Presentation at Upcoming American Thoracic Society 2022 International Conference
WARREN, N.J., May 12, 2022 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or…
News
CorMedix Inc. Announces Leadership Updates and Operational Changes
BERKELEY HEIGHTS, N.J., May 12, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Longboard Pharmaceuticals to Participate in Upcoming Investor Events
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage…
Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference
CINCINNATI, May 12, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
$23.5 Million in Cash and Investments as of March 31, 2022, Expected to Support Completion…
Vallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR
PHILADELPHIA, PA, May 12, 2022 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or…
ABVC BioPharma, Inc. Announces $4.22 Million Registered Direct Offering
Fremont, CA, May 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (“ABVC” or the “Company”)…
Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
Virtual event on Monday, May 23rd at 11:00 AM ET The webinar will provide a…
Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System
TiHawk11 Interbody Fusion System Accelus recently received U.S. FDA 510(k) Clearance for its TiHawk11, the…
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
– Attaining CE Mark is a major step toward commercialization – – World Health Organization (WHO)…
Update on Positive Pre-Clinical Results from AIM Biologicals Development Program for the Potential Treatment of Parkinson’s Disease
– Data presented at IMMUNOLOGY2022™, the Annual Event of the American Association of Immunologists –…
AIM ImmunoTech to Participate in a Solve M.E. Signature Event: ‘Long COVID: Research, Policy, and Economic Impact’ on May 19, 2022
OCALA, Fla., May 12, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM”…
Phase 4 PALADIN Study Confirms Positive Predictive Value of Corticosteroid Course Prior to ILUVIEN® Use for IOP Outcomes
Recently presented data further demonstrate steroid challenge is highly predictive of IOP response post-FAc regardless…
Elicio Therapeutics Announces Appointment of Joy Seymour as Vice President, Head of Regulatory Affairs and Promotion of Dr. Peter DeMuth to Chief Scientific Officer
BOSTON, May 12, 2022 (GLOBE NEWSWIRE) — Elicio Therapeutics, a clinical-stage biotechnology company developing a…
Amarin to Present at Two Upcoming Investor Conferences
DUBLIN, Ireland and BRIDGEWATER, N.J., May 12, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN)…
COMPASS Pathways to participate in upcoming Citi’s Biopharma Virtual Co-Panel Day and H.C. Wainwright Global Investment Conference
LONDON, May 12, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
Impel Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical…
LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update
LianBio’s partner, Bristol Myers Squibb, has received U.S. FDA approval of mavacamten for the treatment…
Imago BioSciences Announces Upcoming Presentations on Updated Data from Phase 2 Studies of Bomedemstat for the Treatment of Essential Thrombocythemia and Myelofibrosis at the 27th Congress of the European Hematology Association (EHA) for 2022
SOUTH SAN FRANCISCO, Calif., May 12, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO),…
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Cash position bolstered through debt financing to support operations into the fourth quarter of 2023…